QA0.0131
SLC6A1-related disorder
Clinical Classification Guidelines
Inclusion Terms
- GABA transporter 1 deficiency
Medical Intelligence & Overview
SLC6A1-related disorder is a rare genetic condition caused by a deficiency in the GABA transporter 1, a protein responsible for the regulation of the neurotransmitter GABA in the brain. This disorder impacts neurological development and can lead to a range of neurological symptoms. It is classified under ICD-10 code QA0.0131, highlighting its status as a specific genetic and neurological disorder. The condition is often diagnosed in childhood and can vary in severity among individuals. Understanding the disorder involves exploring its causes, symptoms, diagnosis process, and potential management approaches.
Causes & Symptoms
Clinical Causes: Genetic mutations in the SLC6A1 gene, inherited or occurring de novo Disruptions in the production or function of the GABA transporter 1 protein Increased or decreased GABA levels affecting neuronal communication No environmental factors directly cause this disorder, as it is primarily genetic
Key Symptoms: Developmental delays and learning difficulties Seizures or epileptic activity, especially status epilepticus Autism spectrum behaviors or social communication challenges Breathing irregularities during sleep Motor coordination issues or muscular hypotonia Behavioral issues, including hyperactivity or impulsivity
Diagnostic & Treatment
Diagnosis Path: The diagnosis process involves a combination of clinical evaluations, neurodevelopmental assessments, and genetic testing. Genetic sequencing of the SLC6A1 gene can confirm mutations responsible for the disorder. EEG studies may be conducted to monitor seizure activity, while neuroimaging studies like MRI can help rule out other neurological conditions. Since the symptoms can overlap with other neurodevelopmental disorders, a thorough evaluation by specialists in genetics and neurology is essential to establish an accurate diagnosis.
Treatment Protocols: Antiepileptic medications to control seizures Developmental and behavioral therapies, such as occupational, speech, and behavioral therapy Educational support tailored to the child's needs Supportive care for motor and communication challenges Regular monitoring by a multidisciplinary team to adjust interventions as needed
Clinical Advice & FAQs
Billing Guidance
Is QA0.0131 a billable ICD-10 code?
Yes, QA0.0131 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report QA0.0131?
Clinical documentation must specify the nature of SLC6A1-related disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference